BRAIN NEOPLASMS
Clinical trials for BRAIN NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new BRAIN NEOPLASMS trials appear
Sign up with your email to follow new studies for BRAIN NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo targets Hard-to-Treat BRAF cancers in early trial
Disease control TerminatedThis early-phase study tested a new drug called PF-07284890, alone or with another drug (binimetinib), in people with advanced solid tumors that have a specific BRAF V600 mutation, including those with brain tumors. The main goals were to check safety, how the drug moves through …
Matched conditions: BRAIN NEOPLASMS
Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control
Last updated May 12, 2026 13:41 UTC
-
New imaging agent shows promise for detecting Hard-to-Treat cancers
Diagnosis TerminatedThis study tested a new imaging agent called 68Ga-FF58 in 14 adults with certain advanced solid tumors, including glioblastoma and pancreatic cancer. The goal was to see how well it shows up on PET/CT scans and to check its safety. The study was stopped early, so results are limi…
Matched conditions: BRAIN NEOPLASMS
Phase: EARLY_PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Diagnosis
Last updated May 11, 2026 20:49 UTC